Stock Analysis News 1 November 2025

Pinterest Stock Plunges 18% on Earnings Miss – Can AI and Record Users Fuel a Rebound?

Recent News & Market Reaction Pinterest stock tumbled after its latest earnings release, with shares sinking 18% on Nov. 5 as the company’s weak holiday-quarter outlook spooked investors investing.com. The steep drop – the stock’s worst single-day slide in years

5 November 2025

Zeta Global (ZETA) – 17th Straight Beat & Raise Quarter Ignites AI-Cloud Rally – Analysts Eye ~$28 Target (≈+70% Upside)

Stock Performance & Valuation Zeta’s stock has trended down from its late-2024 highs (~$36.7) as broader growth-tech valuation pressures emerged. At the Nov 4 close, ZETA was ~$16.70 stockanalysis.com, near its 52-week low and well below its peak. Over the

4 November 2025

AI Technology · Cloud Computing · Earnings Reports · Investment Ideas · NYSE:ZETA · Stock Analysis

Is ALAR Stock the Next AI Goldmine? Discover Alarum’s Explosive Run and What Analysts Are Saying

Stock Price Performance (as of Nov 4, 2025) Alarum Technologies (NYSE: ALAR) has rallied strongly in 2025. After closing around $16.25 on Nov 3 stockinvest.us, the stock is off its all-time high (~$18.00) but still stands well above its 2024

4 November 2025

Analyst Opinions · Artificial Intelligence · Investment Opportunities · Market Trends · Stock Analysis

CAVA Group Stock: 20% Growth vs 60% Plunge – What’s Really Happening?

Stock Price & Recent Performance Cava’s stock has fallen sharply in 2025. After peaking near $172 in late 2024, it traded around $51.7 at the Nov. 4, 2025 close stockanalysis.com. That marks a roughly 60% drop from its high and

4 November 2025

Financial News · Growth Stocks · Investment Strategies · Market Trends · NYSE:CAVA · Stock Analysis

Plug Power Stock Skyrockets on Hydrogen Hype – Will PLUG Keep Soaring? (Nov 2025 Update)

Plug Power Stock Forecast: Will PLUG Soar or Slip by End of 2025?

Recent Price Action and Technical Trends Plug Power’s stock chart in 2025 tells a rollercoaster story. After languishing below $1 per share in mid-year, PLUG staged a stunning comeback in late summer and early fall. From August to early October,

4 November 2025

Financial Predictions · Investing · Market Trends · NASDAQ:PLUG · Renewable Energy · Stock Analysis

AT&T Stock 2025: 5G Ambitions, Big Dividend – Telecom Titan or Trap?

Company & Stock Overview AT&T Inc. is a telecom giant with a 140+ year legacy, now focused squarely on connectivity services. Its business model centers on providing voice and data communication to consumers and businesses via an expansive wireless network

4 November 2025

5G Technology · Dividends · Investment Strategies · NYSE:T · Stock Analysis · Telecommunications

Zoetis 2025: Animal Health Giant’s Latest Breakthroughs, Stock Outlook & Key Investor Insights

Company Overview & 2025 Developments Zoetis is the global frontrunner in animal health, offering a diverse portfolio for both companion animals (pets) and farm animals. The company’s products range from vaccines and parasiticides to dermatology treatments and high-tech diagnostics. This

4 November 2025

Animal Health · Biotechnology · Investment Insights · NYSE:ZTS · Pharmaceutical Industry · Stock Analysis

Iovance Biotherapeutics (IOVA): TIL Cancer Breakthrough or Biotech Bust?

Company Overview: Pioneering TIL Therapy in Oncology Iovance Biotherapeutics is focused on developing tumor-infiltrating lymphocyte (TIL) therapies – a novel form of immunotherapy where a patient’s own T cells, harvested from their tumor, are expanded and activated in a lab,

3 November 2025

Biotech · Cancer Research · Immunotherapy · Medical Innovation · NASDAQ:IOVA · Stock Analysis

Acrivon Therapeutics (ACRV): Precision Oncology Game-Changer or Overhyped Biotech Bet?

Company Overview and Background Acrivon Therapeutics is a Boston-area biotech (NASDAQ: ACRV) founded in 2018, emerging with a mission to revolutionize cancer treatment through precision medicine stockanalysis.com. The company’s name “Acrivon” is derived from “accurate” or “precision,” reflecting its core

3 November 2025

Biotechnology · Cancer Research · Healthcare Innovation · NASDAQ:ACRV · Precision Oncology · Stock Analysis

IDEXX Laboratories (IDXX): Inside the Pet Diagnostics Leader’s 2025 Breakout 🚀

Company Overview & Business Segments IDEXX Laboratories facility in Markham, Canada (one of the company’s global offices). IDEXX Laboratories, Inc. is a veterinary diagnostics and life sciences company that develops, manufactures, and sells products and services for animal health and

3 November 2025

Animal Care · Investment Insights · NASDAQ:IDXX · Pet Health · Stock Analysis · Veterinary Diagnostics

Chipotle Stock’s Worst Slump Since 2012 – Bulls and Bears Clash on CMG’s Future

Current Stock Price and Recent Performance A Chipotle Mexican Grill storefront. The burrito chain’s shares suffered a sharp sell-off in late October 2025. Chipotle’s stock has been reeling in the wake of its Q3 report. After closing at $39.76 just

2 November 2025

Bull vs Bear · Chipotle · Company News · Market Trends · NYSE:CMG · Stock Analysis

Rani Therapeutics (RANI) Stock Skyrockets ~200% on $1B Pharma Deal – Will the Rally Last?

Rani Therapeutics Stock Explodes on Obesity-Drug Breakthrough – Analysts Eye $10+ Targets

Stock Performance and Recent Movement Rani shares have exploded in the last month. On Oct 1, 2025 RANI traded around $0.50. A landmark collaboration announced Oct 17 with Japan’s Chugai (up to $1.085B deal) and a simultaneous $60M financing sent

1 November 2025

Biotech · Health Innovation · NASDAQ:RANI · Obesity · Pharmaceuticals · Stock Analysis

Stock Analysis News 1 November 2025 - 5 November 2025